Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

100.09
+1.231.24%
Post-market: 100.090.00000.00%19:43 EDT
Volume:342.44K
Turnover:34.21M
Market Cap:1.54B
PE:9.32
High:100.35
Open:98.35
Low:98.35
Close:98.86
52wk High:108.66
52wk Low:72.94
Shares:15.40M
Float Shares:15.40M
Volume Ratio:0.75
T/O Rate:2.22%
Dividend:1.43
Dividend Rate:1.43%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bristol-Myers Squibb Company - Zdd Median Pfs 42 Months vs 20 Months for Dvd; 51% Risk Reduction

THOMSON REUTERS
·
Oct 08

Bristol-Myers Squibb Company - Serious Adverse Reactions in 58.3% and Fatal in 4.9% of Zenbexus Patients

THOMSON REUTERS
·
Oct 08

Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)

TIPRANKS
·
Oct 08

Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone

Benzinga Earnings
·
Oct 08

Health Care up on Defensive Bias

Dow Jones
·
Oct 08

3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List

TIPRANKS
·
Oct 08

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 08

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 08

Sector Update: Healthcare

MT Newswires Live
·
Oct 08

Moderna, Merck Climb on Collaboration with Tempus

Reuters
·
Oct 08

Eli Lilly and Co Stock (LLY) Moved Up by 3.94% on Oct 7: Facts Behind the Movement

TradingKey
·
Oct 08

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
Oct 08

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Oct 08

Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts

Reuters
·
Oct 07

Eli Lilly is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Oct 07

What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders

Simply Wall St.
·
Oct 07

Halozyme Therapeutics Shares up 2% After Court Win Against Merck to Block Subcutaneous Keytruda in Select Markets

THOMSON REUTERS
·
Oct 07

Morgan Stanley Adjusts Price Target on Merck to $177 From $179

MT Newswires Live
·
Oct 07

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Oct 07

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Oct 07